v3.26.1
STOCKHOLDERS’ EQUITY (DEFICIT) (Tables)
9 Months Ended 12 Months Ended
Mar. 31, 2026
Jun. 30, 2025
Equity [Abstract]    
SUMMARY OF WARRANT ACTIVITY

The following table summarizes warrant activity for the nine months ended March 31, 2026:

       Weighted 
   Number of   Average 
   Warrants   Price Per Share 
Outstanding at June 30, 2025   10   $15,000.00 
Granted – Common stock warrants   1,200    100.00 
Granted – Series C preferred stock warrants   9,900    10,000 
Exercised – Series C preferred stock warrants   (100)   10,000 
Forfeited   -    - 
Expired   -    - 
Outstanding at March 31, 2026   11,010   $8,925.52 
           
Exercisable at March 31, 2026   11,010   $8,925.52 
Outstanding and Exercisable:          
           
Weighted average remaining contractual term   3.67      
Aggregate intrinsic value   $-      

The following table summarizes common stock warrant activity for the years ended June 30, 2025 and 2024:

 

       Weighted 
   Number of   Average 
   Warrants   Price Per Share 
Outstanding at June 30, 2023   -   $8,160,000,000 
Issued   10    15,000 
Exercised   -    - 
Forfeited   -    - 
Expired   -    - 
Outstanding at June 30, 2024   10   $31.00 
Issued   -    - 
Exercised   -    - 
Cancelled*   -    - 
Expired   -    - 
Outstanding at June 30, 2025   10   $0.25 
           
Exercisable at June 30, 2025   10   $0.25 
Outstanding and Exercisable:          
           
Weighted average remaining contractual term   1.01      
Aggregate intrinsic value  $1,035      

 

* On March 3, 2025, the Company cancelled all the existing warrants (de minimis number of shares of Series A warrants, Series B warrants, and Series C warrants) held by an investor pursuant to a Warrant Exchange Agreement (see above).
SCHEDULE OF SHARE BASED COMPENSATION STOCK OPTIONS ACTIVITY

A summary of the Company’s option activity during the nine months ended March 31, 2026 is presented below:

       Weighted 
   Number of   Average Exercise 
   Shares   Price Per Share 
Outstanding at June 30, 2025   nil   $6,800,000,000,000 
Granted   -    - 
Exercised   -    - 
Forfeited   -    - 
Expired   -    - 
Outstanding at March 31, 2026   nil   $6,800,000,000,000 
           
Exercisable at March 31, 2026   nil   $6,800,000,000,000 
Outstanding and Exercisable:          
           
Weighted average remaining contractual term   3.12      
Weighted average fair value of options granted during the period  $-      
Aggregate intrinsic value  $-      

A summary of the Company’s stock option activity during the years ended June 30, 2025 and 2024 is presented below:

 

       Weighted 
   Number of   Average 
   Options   Price Per Share 
Outstanding at June 30, 2023   nil   $6,800,000,000,000 
Issued   -    - 
Exercised   -    - 
Expired   -    - 
Outstanding at June 30, 2024   nil   $6,800,000,000,000 
Issued   -    - 
Exercised   -    - 
Expired   -    - 
Outstanding at June 30, 2025   nil   $6,800,000,000,000 
           
Exercisable at June 30, 2025   nil   $6,800,000,000,000 
Outstanding and Exercisable:          
           
Weighted average remaining contractual term   3.87      
Weighted average fair value of options granted during the year  $-      
Aggregate intrinsic value  $-